Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, expectations were $0.914. Operator: Good morning and thank you all for ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ascendis Pharma (ASND – Research Report), Tenet ...

CVS Health Corp (CVS) reports robust revenue growth and strategic advancements, while navigating financial pressures and ...

With a market cap of $491.4 billion, UnitedHealth Group Incorporated (UNH) Incorporated is a leading diversified health care ...

Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

UBS analyst Olivier Calvet maintained a Sell rating on Redcare Pharmacy (0RJT – Research Report) today and set a price target of €85.00. The ...

Investing.com - CVS Health has posted better-than-anticipated income and revenue in the fourth quarter, as the healthcare group pursues a broad overhaul of its operations under new Chief Executive ...